Showing results (1181-1190 of 2,266) with videos related to
Sort By:
Pageof 227
Free Radical Biology & Medicine|January 1, 1997
Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseasesT Grune, P Michel, N Sitte, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2009
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility--an open-label, 6-week studyKarla Eggert, Orjan Skogar, Khaled Amar, et al.European Journal of Immunology|October 3, 1999
Generation and functional characterization of mouse monocyte-derived dendritic cellsM W Schreurs, A A Eggert, A J de Boer, et al.Journal of Medical Microbiology|July 7, 2016
Variability of Pasteurella multocida isolated from Icelandic sheep and detection of the toxA geneThorbjorg Einarsdottir, Eggert Gunnarsson, Olof G Sigurdardottir, et al.Medical and Pediatric Oncology|December 7, 2000
Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expressionA Eggert, M A Grotzer, T J Zuzak, et al.Clinical Neuropharmacology|June 4, 2008
Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complicationsKarla Eggert, Christoph Schrader, Michaela Hahn, et al.Cytogenetic and Genome Research|June 27, 2015
2q37.3 Deletion Syndrome: Two Cases with Highly Distinctive Facial Phenotype, Discordant Association with Schizophrenic Psychosis, and Shared Deletion Breakpoint Region on 2q37.3Yasmin Mehraein, Martina Pfob, Ortrud Steinlein, et al.The International Journal of Artificial Organs|April 9, 2005
Phosphorus-enriched hemodialysis for the treatment of patients with severe methanol intoxicationS B Chebrolu, A Hariman, C H Eggert, et al.Clinical Transplantation|March 19, 2010
mTOR inhibitor-associated dermatologic and mucosal problemsJosep M Campistol, Johan W de Fijter, Stuart M Flechner, et al.European Journal of Neurology|August 22, 2008
Clinical risk-benefit assessment of dopamine agonistsJ C Möller, K M Eggert, M Unger, et al.Pageof 227